HS Icon Medicaments nes, formulated, in bulk

300390 (Harmonized System 1992 for 6-digit)

World Trade (2018): $14.8B, Rnk 192 / 4726

Top Exporter (2018): $6.53B, Germany

Top Importer (2018): $6.44B, Ireland

Product Complexity (2018): 0.46, Rnk 1773 / 4873

Export Growth (CAGR)(2017 - 2018): 124%, Rnk 63 / 4726

Mean Tariff (2018): 4.82%, Rnk 4282 / 6538

Share of World Trade (2018): 0.08%, Rnk 192 / 4726

Overview:  This page contains the latest trade data of Medicaments nes, formulated, in bulk. In 2018, Medicaments nes, formulated, in bulk were the world's 192nd most traded product, with a total trade of $14.8B. Between 2017 and 2018 the exports of Medicaments nes, formulated, in bulk grew by 124%, from  $6.59B to $14.8B. Trade in Medicaments nes, formulated, in bulk represent 0.08% of total world trade.

Exports: In 2018 the top exporters of Medicaments nes, formulated, in bulk  were Germany ($6.53B), Netherlands ($1.62B), United States ($1.15B), Singapore ($595M), and Switzerland ($445M).

Imports: In 2018 the top importers of Medicaments nes, formulated, in bulk were Ireland ($6.44B), United Kingdom ($1.85B), United States ($1.71B), Germany ($707M), and Netherlands ($487M).

Tariffs: In 2018 the average tariff for Medicaments nes, formulated, in bulk was 4.82%, been the 4282 lowest tariff using the HS6 product classification.

The countries with the highest import tariffs for Medicaments nes, formulated, in bulk are Iran (34.5%), Belize (12.7%), Nepal (11.6%), Barbados (11.2%), and Pakistan (10.8%). The countries with the lowest tariffs are Angola (0%), Cote d'Ivoire (0%), Ghana (0%), Guinea (0%), and Kenya (0%).

Ranking: Medicaments nes, formulated, in bulk ranks 1773rd in the Product Complexity Index (PCI).

Exporters and Importers

#permalink to section

Trade By Country

Top Origin (2018): Germany, $6.53B

Top Destination (2018): Ireland, $6.44B

Medicaments nes, formulated, in bulk are the world's 192nd most traded product.

In 2018, the top exporters of Medicaments nes, formulated, in bulk were Germany ($6.53B), Netherlands ($1.62B), United States ($1.15B), Singapore ($595M), and Switzerland ($445M).

In 2018, the top importers of Medicaments nes, formulated, in bulk were Ireland ($6.44B), United Kingdom ($1.85B), United States ($1.71B), Germany ($707M), and Netherlands ($487M).

Explore Visualizations

Market Dynamics

#permalink to section

Trade by country

Value

Top Origin Growth (2017 -  2018): Germany, $5.16B

Top Destination Growth (2017 - 2018): Ireland, $4.66B

Between 2017 and 2018, the exports of Medicaments nes, formulated, in bulk grew the fastest in Germany ($5.16B), Netherlands ($1.3B), Singapore ($594M), Israel ($388M), and Spain ($187M).

Between 2017 and 2018, the fastest growing importers of Medicaments nes, formulated, in bulk were Ireland ($4.66B), United Kingdom ($1.47B), United States ($1.17B), Netherlands ($278M), and Germany ($239M).

Explore Visualizations

Market Concentration

#permalink to section

Cumulative market share

This chart shows the evolution of the market concentration of exports of Medicaments nes, formulated, in bulk.

In 2018,  market concentration measured using Shannon Entropy, was 3.41. This means that most of the exports of Medicaments nes, formulated, in bulk are explained by 10 countries.

Explore Visualizations

TOP NET EXPORTER (2018): Germany, $5.83B

TOP NET IMPORTER (2018): Ireland, $6.23B

This map shows which countries export or import more of Medicaments nes, formulated, in bulk. Each country is colored based on the difference in exports and imports of Medicaments nes, formulated, in bulk during 2018.

In 2018, the countries that had a largest trade value in exports than in imports of Medicaments nes, formulated, in bulk were Germany ($5.83B), Netherlands ($1.13B), Singapore ($581M), Israel ($376M), and India ($256M).

In 2018, the countries that had a largest trade value in imports than in exports of Medicaments nes, formulated, in bulk were Ireland ($6.23B), United Kingdom ($1.53B), United States ($567M), Russia ($110M), and Algeria ($108M).

Trade Forecasts

#permalink to section

This section shows forecasts for total trade for Medicaments nes, formulated, in bulk. The forecast is based in a long short-term memory model or LSTM constructed using yearly trade data.

Explore Forecasts

Import Tariffs

#permalink to section

In 2018, the average tariff for importing Medicaments nes, formulated, in bulk was 4.82%.  The countries with the highest tariffs for importing Medicaments nes, formulated, in bulk were Iran (34.5%), Belize (12.7%), Nepal (11.6%), Barbados (11.2%), and Pakistan (10.8%).

Explore Tariff Data

Product Complexity

#permalink to section

Diversification Frontier

#permalink to section
Filter

The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.